Professor, Internal Medicine, University of Cincinnati College of Medicine
Gastroenterology
Dr. Bruce Yacyshyn, MD
|
|
Give Review
Bruce Yacyshyn works in the field of Gastroenterology. He has 3 awards "CMS Meaningful Use Stage 1 Certification", "Fellow (AGAF)" and "Fellow (FACG)". Bruce Yacyshyn is also published. He has 39 publications published. The lastest publication: "Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile.
- Human Clostridium difficile infection: altered mucus production and composition.
- High- and Low-Dose Oral Delayed-Release Mesalamine in Children With Mild-to-Moderately Active Ulcerative Colitis.
- Clostridium difficile recurrence is characterized by pro-inflammatory peripheral blood mononuclear cell (PBMC) phenotype.
- The Role of Gut Inflammation in Recurrent CDAD.
- Clinical validation of the Helikit: a 13C urea breath test used for the diagnosis of Helicobacter pylori infection.
- Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: ...
- Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
- Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis.
- Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability.
- The clinical experience of antisense therapy to ICAM-1 in Crohn''s disease.
- A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with a...
- Adhesion molecule therapeutics in IBD.
- Antisense oligonucleotide treatment of inflammatory bowel diseases.
- Discussion on the safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.
- Prevalence of occult gastrointestinal bleeding in celiac disease.
- New biotechnological therapies for Crohn''s disease: where are we now?
- Gene polymorphisms and serological markers of patients with active Crohn''s disease in a clinical trial of antisense to ICAM-1.
- The clinical importance of proton pump inhibitor pharmacokinetics.
- Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn''s disease.
- Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2...
- Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), i...
- The concept and application of antisense oligonucleotides.
- Critical review of acid suppression in nonvariceal, acute, uppergastrointestinal bleeding.
- Alterations in protein kinase C isoforms in experimentally-induced colitis in the rat.
- Making sense of antisense.
- Preclinical and clinical pharmacology of antisense oligonucleotides.
- Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives.
- Drug treatment for Crohn''s disease.
- A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease.
- Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytes.
- Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis.
- Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma.
- CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability.
- Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.
- Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero.
- Expression of CD45RO on circulating CD19+ B-cells in Crohn''s disease.
- Beta 1 integrin (CD29) expression on human postnatal T cell subsets defined by selective CD45 isoform expression.
Schools
University of Alberta Faculty of Medicine And Dentistry
Edmonton Genl Hospital
Sunnybrook Hospital
Toronto Genl
Barnes HospWash University
Doctors Specialties
- Internal Medicine
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (AGAF)
- Fellow (FACG)
Education
-
Washington University - Barnes-Jewish Hospital -
University of Alberta Faculty of Medicine
Hospital
-
University of Cincinnati Medical Center
Drug Facts
| NPI NUMBER | 1467466771 | |
| NPPES Provider LastName | YACYSHYN | |
| NPPES Provider FirstName | BRUCE | |
| NPPES Provider ZIPCode | 452194231 | |
| NPPES Provider State | OH | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 112.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467466771 |
| Last Name Of The Provider | YACYSHYN |
| First Name Of The Provider | BRUCE |
| View All |
Similar Doctors
|
|
Dr. Katheryn E. Jadeed, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vidhya Kunnathur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc A. Alexander, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joori Flateau, DO |
|
|
Dr. Geraldine M. Vehr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maryam Gul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark E. Jonas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manojkumar S. Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen E. Haberthier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Loughrey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maritza Palusiak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald J. Weisenberger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Khurram Bari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia K. Robinson, MD |